摘要
Purpose: The present study was to examine the effect of sphingosine kinase-1 (SPHK1) on chemother-apeutics-induced apoptosis in non-small cell lung cancer (NSCLC) cells, which is relatively insensitive to chemotherapy, and its clinical significance in NSCLC progression. <br>Experimental Design: The correlation of SPHK1 expression and clinical features of NSCLC was analyzed in 218 paraffin-embedded archived NSCLC specimens by immunohistochemical analysis. The effect of SPHK1 on apoptosis induced by chemotherapeutics was examined both in vitro and in vivo, using Annexin V staining and TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assays. Western blotting and luciferase analysis were performed to examine the impact of SPHK1 on the PI3K/Akt /NF-kappa B signaling. <br>Results: The expression of SPHK1 was markedly increased in NSCLC and correlated with tumor progression and poor survival of patients with NSCLC. Upregulation of SPHK1 significantly inhibited doxorubicin-or docetaxel-induced apoptosis, associated with induction of antiapoptotic proteins Bcl-xl, cIAP1, c-IAP2, and TRAF1. In contrast, silencing SPHK1 expression or inhibiting SPHK1 activity with specific inhibitor, SK1-I, significantly enhanced the sensitivity of NSCLC cells to apoptosis induced by chemotherapeutics both in vitro and in vivo. Moreover, we demonstrated that upregulation of SPHK1 activated the PI3K/Akt/NF-kappa B pathway, and that inhibition of the PI3K/Akt/NF-kappa B pathway abrogated the antiapoptotic effect of SPHK1 on NSCLC cells. <br>Conclusions: Our results suggest that SPHK1 is a potential pharmacologic target for the treatment of NSCLC and inhibition of SPHK1 expression or its kinase activity might represent a novel strategy to sensitize NSCLC to chemotherapy. Clin Cancer Res; 17(7); 1839-49.
- Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung CancerLin, Zhoujun; Li, Yin; Han, Xiao; Fu, Zhenkun; Tian, Zhenhuan*; Li, Chenggang*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(21): 12741.被引 3
- Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma CellsGuan Hongyu*; Song Libing; Cai Junchao; Huang Yongbo; Wu Jueheng; Yuan Jie; Li Jun; Li MengfengPLoS ONE, 2011, 6(5): e19946.被引 39
- Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinomaBao, Ji-Ming*; Zhi, Xi; Yuan, Hao-Yu; Chen, Tao-Yi; Chen, Ming-Kun; Zhou, Jun-Hao; Xue, Kang-Yi; Yang, Jian-Kun*; Liu, Cun-Dong*Translational Cancer Research, 2023, 12(3): 572-584.
